SIADH nursing: assessment, interventions, and NCLEX review

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is among the most frequently tested electrolyte disorders on the NCLEX — and one of the most dangerous to mismanage at the bedside. The disorder causes dilutional hyponatremia by trapping free water, and the consequences range from subtle cognitive changes to fatal seizures and brainstem herniation. Correcting it too aggressively is equally dangerous: overcorrection causes osmotic demyelination syndrome (ODS), an irreversible brainstem injury previously called central pontine myelinolysis.

Nurses are the first to detect the signs — a patient becoming confused, a sodium trending down, a urine output that seems paradoxically low. This reference covers the full clinical picture: pathophysiology, diagnostic criteria, cause identification, fluid restriction management, hypertonic saline safety, the critical differentiation from cerebral salt wasting (CSWS), and the nursing interventions that keep patients safe. Pair this article with the broader electrolyte imbalances reference for complete coverage.

Quick reference: SIADH at a glance

Pathophysiology: why SIADH causes dilutional hyponatremia

ADH (antidiuretic hormone, also called vasopressin or arginine vasopressin/AVP) is a peptide hormone produced in the hypothalamus and released from the posterior pituitary. Its normal job is to regulate water balance: when serum osmolality rises or blood volume falls, ADH is released and binds to V2 receptors in the renal collecting ducts. This triggers insertion of aquaporin-2 water channels into the tubular membrane, allowing water to move from the filtrate back into the bloodstream. The result is concentrated urine and restored blood volume.

Under normal physiology, ADH release is tightly regulated. When osmolality normalizes, ADH secretion stops and the kidney excretes dilute urine. In SIADH, this feedback loop breaks down. ADH is secreted continuously — regardless of serum osmolality or volume status. The kidneys respond appropriately to the signal they receive: they retain free water, producing concentrated urine. But the signal itself is pathological.

The consequences cascade predictably:

1. Free water accumulates in the vascular compartment, diluting all solutes — including sodium.
2. Serum osmolality falls. Because sodium is the primary determinant of serum osmolality, hyponatremia and hypo-osmolality appear together.
3. The kidneys, responding to mild volume expansion, continue to excrete sodium in the urine. Urine sodium remains high even though serum sodium is critically low.
4. Water shifts along osmotic gradients into brain cells. Cerebral edema develops. Neurological symptoms follow.

The severity of symptoms depends on two factors: how low the sodium falls, and how fast it fell. Chronic slow declines (over days to weeks) give brain cells time to adapt by releasing osmoles — patients tolerate surprisingly low sodium levels with minimal symptoms. Acute drops (over hours) allow no adaptation — even a fall to 125 mEq/L can cause seizures.

Causes of SIADH

The trigger for inappropriate ADH secretion falls into four main categories. Identifying the cause matters because treating the underlying condition is part of definitive management.

Clinical note: Meningitis is a classic CNS cause of SIADH — the inflammatory response in the meninges stimulates hypothalamic ADH release. In any patient with CNS infection who develops worsening confusion, check the sodium. Guillain-Barré syndrome can also trigger SIADH through autonomic dysregulation. For ectopic ADH, small cell lung cancer is the archetype — see the lung cancer nursing reference for the broader oncology context.

Diagnostic criteria: the Schwartz-Bartter criteria

SIADH is a diagnosis of exclusion. The classic Schwartz-Bartter criteria (established 1967, still in clinical use) require all of the following:

The urine osmolality criterion is particularly important. In SIADH, the urine is inappropriately concentrated relative to the serum. A healthy kidney seeing low serum osmolality should produce maximally dilute urine (as low as 50–100 mOsm/kg). Urine osmolality above 100 mOsm/kg in the setting of serum hypo-osmolality tells you the kidney is acting under the influence of ADH — even when it should not be.

Clinical presentation by sodium level

Symptoms correlate primarily with the degree of hyponatremia, modified by the speed of onset.

Key nursing insight: Acute hyponatremia (developing over <48 hours) is far more dangerous than chronic hyponatremia at the same sodium value. A patient whose sodium dropped from 140 to 125 mEq/L in six hours is at higher seizure risk than a patient with a chronic sodium of 118 mEq/L who is wide awake and answering questions. Time course matters as much as the absolute value.

Treatment priorities

First-line: fluid restriction

Fluid restriction is the cornerstone of SIADH management in all but the most severe cases. By limiting free water intake, you stop adding to the dilutional load and allow insensible losses (respiration, perspiration) to gradually concentrate the serum.

Standard restriction: 800–1000 mL total fluid per day (some sources cite 500–1000 mL depending on the severity of hyponatremia and degree of urine concentration).

Implementation points for nurses:

• All fluids count: oral intake, IV fluids, medications given in NS or D5W flushes, ice chips. Document meticulously.
• Explain the rationale to the patient and family. Patients who understand why restriction matters are more adherent.
• A urine osmolality >500 mOsm/kg indicates the kidneys are concentrating aggressively — fluid restriction may not be sufficient alone, and medications may be needed sooner.
• Dry mouth and thirst are common complaints. Offer ice chips counted toward the restriction; oral care with a damp swab helps.
• Expected correction: sodium typically rises 1–2 mEq/L per day with fluid restriction alone.

Hypertonic saline (3% NaCl): when and how

Hypertonic saline is reserved for severe symptomatic hyponatremia — defined as sodium <120 mEq/L with active seizures, obtundation, respiratory failure, or impending herniation. It is not given for asymptomatic hyponatremia or mild symptoms regardless of the sodium value.

Administration protocol:

• Rate: no faster than 1–2 mEq/L per hour
• Goal: raise sodium enough to stop acute symptoms (typically 4–6 mEq/L), then switch to fluid restriction
• Maximum correction: 6–8 mEq/L per 24 hours — this is an absolute ceiling, not a target
• Some sources permit up to 10–12 mEq/L in the first 24 hours only in cases of acute symptomatic hyponatremia; beyond the first 24 hours the limit returns to 8 mEq/L/24h
• Route: central line preferred for concentrations >2%; peripheral is used short-term if central access is unavailable
• Monitoring: serum sodium every 2 hours during infusion; stop or slow the infusion if correction rate is exceeded
• Always infuse via infusion pump — never gravity drip

Why the correction rate matters — osmotic demyelination syndrome (ODS):

ODS (formerly called central pontine myelinolysis) occurs when chronically hyponatremic brain cells are suddenly exposed to a rapid rise in osmolality. Over days to weeks of low sodium, neurons adapt by ejecting osmolytes to equalize across the cell membrane. If the sodium is corrected faster than those osmolytes can be reacquired, the cells shrink, the myelin sheath demyelinates, and irreversible neurological injury results. ODS classically damages the pons but can involve extrapontine structures.

Clinical presentation of ODS: dysarthria, dysphagia, spastic quadriparesis, locked-in syndrome, or coma — typically appearing 2–6 days after correction. There is no treatment. Prevention is the only strategy: correct slowly.

Patients at highest risk for ODS: chronic hyponatremia (>48 hours), alcohol use disorder, malnutrition, liver disease, hypokalemia. These patients should be corrected at the lower end of the safe range (6 mEq/L/24h).

For context on how SIADH-driven hyponatremia differs from the hyperosmolar state seen in HHS, review that reference — the management directions are opposite.

SIADH vs CSWS: the most dangerous differential in nursing practice

Cerebral salt wasting (CSWS) is the condition most commonly confused with SIADH. Both cause hyponatremia with a high urine sodium. Getting this wrong is not a documentation error — it is a patient safety emergency. Treating CSWS with fluid restriction (the correct treatment for SIADH) will cause cardiovascular collapse. Treating SIADH with saline volume expansion (the correct treatment for CSWS) will worsen hyponatremia.

The single distinguishing factor is volume status.

Clinical context: CSWS occurs almost exclusively in the setting of brain injury — most commonly subarachnoid hemorrhage, traumatic brain injury, or neurosurgery. The mechanism is incompletely understood but likely involves natriuretic peptides (ANP, BNP, and brain natriuretic peptide) released from injured neural tissue, overriding normal renal sodium reabsorption. SIADH occurs in a far broader range of conditions.

Nursing assessment tip: The fastest bedside screen is volume status. In SIADH, the patient looks clinically euvolemic — blood pressure is normal, skin turgor is normal, mucous membranes are moist, and there is no orthostatic hypotension. In CSWS, the patient looks dehydrated. If you are caring for a patient with a recent subarachnoid hemorrhage or craniotomy who develops hyponatremia, CSWS must be strongly considered before starting fluid restriction.

Nursing interventions

Neurological monitoring

• Neuro checks every 2–4 hours in any patient with symptomatic hyponatremia — level of consciousness, orientation (person, place, time, situation), GCS score where indicated
• Document the baseline and track the trend. Subtle deterioration — a patient who was oriented × 4 and is now oriented × 2 — is the earliest actionable warning
• Report worsening confusion, new headache, or any change in speech immediately
• Seizure precautions for sodium <125 mEq/L or any patient with symptomatic hyponatremia: padded side rails, suction at bedside, airway accessible, oral airway available, IV access patent. See the seizure nursing reference for full seizure management protocols
• Fall precautions for all patients with altered sensorium: call light within reach, non-skid footwear, bed in lowest position, frequent rounding

Fluid and sodium monitoring

• Strict intake and output (I&O) every hour in severe hyponatremia; every 4–8 hours in mild to moderate
• Daily weights at the same time, same scale, same clothing — weight gain indicates further water retention; weight loss suggests the restriction is working or the patient is becoming volume-depleted (watch for CSWS)
• During 3% NaCl infusion: serum sodium every 2 hours minimum; adjust rate based on results
• Document all fluid sources meticulously: IV maintenance, IV medications, flushes, oral liquids, tube feeds, ice chips

Fluid restriction implementation

• Communicate the restriction clearly in the nursing handoff and nursing care plan
• Educate the patient and family: explain that thirst is a symptom of the body adjusting, that restriction is temporary, and that drinking more water will make the situation worse
• Distribute the daily fluid allowance across the full 24 hours rather than front-loading — prevents severe thirst by evening
• Coordinate with dietary services to reduce sodium in meals only if clinically indicated (some providers prefer moderate sodium intake to promote mild natriuresis)

Safety measures

• Ensure IV access is patent and functional — rapid access for hypertonic saline or anticonvulsant administration
• Keep the bed in the lowest position; use bed alarms as appropriate
• For patients with decreased gag reflex or significantly altered consciousness, position to reduce aspiration risk; suction available
• In patients with chronic SIADH secondary to malignancy or irreversible CNS injury, coordinate with palliative care regarding the goals of fluid restriction

Medications used in SIADH management

When fluid restriction alone is insufficient — particularly in severe or chronic SIADH — pharmacologic agents may be added.

NCLEX tips

These high-yield points represent the most frequently tested SIADH concepts on NCLEX.

1. The core paradox. In SIADH, the urine is concentrated and the blood is dilute. Urine osmolality is high; serum osmolality is low. This seems backward — understand why it happens (ADH is constantly on, concentrating urine regardless of serum osmolality) and you will answer any SIADH lab question correctly.

2. Fluid restriction is first-line. The NCLEX will often ask what intervention to implement first. The answer for stable SIADH is fluid restriction (800–1000 mL/day) — not sodium supplements, not diuretics.

3. 3% saline is never routine. It is reserved exclusively for sodium <120 mEq/L with active neurological symptoms: seizures, obtundation, or coma. If the NCLEX presents a patient with SIADH and a sodium of 126 mEq/L who is confused but awake, the answer is fluid restriction and monitoring — not hypertonic saline.

4. Correction rate: 6–8 mEq/L per 24 hours. This number appears in NCLEX questions. Faster correction causes osmotic demyelination syndrome (ODS/central pontine myelinolysis). If a question asks what to do when the sodium has already risen 9 mEq/L in 12 hours, the answer is to slow or stop the infusion.

5. ODS is irreversible. No treatment reverses osmotic demyelination syndrome once it occurs. Prevention — slow correction — is the only option. Know the risk factors: chronic hyponatremia, alcohol use disorder, malnutrition, liver disease.

6. SIADH vs CSWS: volume status is the key. Both cause hyponatremia with high urine sodium. SIADH is euvolemic; CSWS is hypovolemic. Treating them the same way is dangerous. Any NCLEX question distinguishing SIADH from CSWS is testing whether you know to assess volume status first.

7. CSWS occurs in brain-injured patients. Subarachnoid hemorrhage, traumatic brain injury, neurosurgery — these are the settings where CSWS appears. SIADH occurs in a much wider range of conditions. If the patient has a recent SAH and develops hyponatremia, CSWS is on the differential.

8. Tolvaptan: do not restrict fluids. This is a NCLEX trick. Vaptans (tolvaptan, conivaptan) work by causing the kidneys to excrete free water — patients must be allowed to drink freely during therapy or overcorrection occurs. This is the opposite of what you do with fluid restriction.

9. SIADH medications: demeclocycline takes days. If a NCLEX question asks which medication has a delayed onset of several days, the answer is demeclocycline. It is not used for acute management — it is for chronic or malignancy-related SIADH.

10. Urine sodium >40 mEq/L despite hyponatremia. This is what makes SIADH distinctive from hyponatremia due to volume depletion (where the kidney conserves sodium and urine sodium is low, typically <20 mEq/L). If urine sodium is high in a hyponatremic patient, think SIADH or CSWS — then distinguish them by volume status.

11. Common drug causes on NCLEX. SSRIs are the most commonly tested medication cause of SIADH. Carbamazepine is the second. If a question presents a patient on sertraline or oxcarbazepine with new confusion and hyponatremia, SIADH from the medication is high on the list.

12. Small cell lung cancer and ectopic ADH. SCLC produces ADH ectopically. Any NCLEX question about a patient with lung cancer who develops hyponatremia should prompt consideration of SIADH. See the lung cancer nursing reference for the oncology context.

13. Neuro checks Q2-4h. The NCLEX will ask about monitoring priority. In symptomatic hyponatremia, neurological assessment — level of consciousness, orientation, pupillary response — is the priority nursing assessment because cerebral edema is the primary risk.

14. Daily weights catch water retention early. Weight gain in a patient with SIADH on fluid restriction means the restriction is not working or is not being followed. One liter of retained water equals approximately one kilogram of weight gain.

Putting it all together: a clinical scenario

A 58-year-old patient with a history of small cell lung cancer is admitted with increasing confusion and headache over three days. Vital signs: BP 124/78, HR 88, afebrile. Mucous membranes moist, skin turgor normal, no peripheral edema. Labs return: serum sodium 121 mEq/L, serum osmolality 252 mOsm/kg, urine sodium 58 mEq/L, urine osmolality 440 mOsm/kg. The patient is oriented to person only.

What you are seeing: Low serum sodium, low serum osmolality, high urine sodium, high urine osmolality, euvolemia, ectopic ADH from SCLC — classic SIADH.

Priority nursing actions:

1. Notify the provider immediately — sodium of 121 mEq/L with confusion requires urgent assessment.
2. Implement seizure precautions and fall precautions.
3. Begin strict I&O and initiate fluid restriction per order (expect 800–1000 mL/day).
4. Neuro checks every 2 hours.
5. Prepare for possible 3% NaCl order if the patient’s neurological status worsens — verify IV access, prime tubing, confirm infusion pump availability.
6. Monitor serum sodium every 2–4 hours initially; do not allow correction to exceed 6–8 mEq/L in 24 hours.
7. Educate patient and family about fluid restriction rationale once orientation improves.

For the full electrolyte context and how SIADH fits into the broader picture of sodium disorders, the electrolyte imbalances nursing reference covers hypernatremia, hypokalemia, hypercalcemia, and all major imbalances in a single article. For management of the opposite osmolar extreme — hyperosmolar hyperglycemic state — see the HHS nursing reference.